Editorial: Preprocedural Computational Modeling — One More Step Toward Precision Medicine in Transcatheter Aortic Valve Replacement?

In a decade’s time, transcatheter aortic valve replacement (TAVR) has evolved from a treatment option reserved for patients with severe, symptomatic aortic stenosis (AS) with a high surgical risk profile to a standard and preferred treatment option for nearly all severe AS patients ≥75 years regardless of the degree of surgical risk.1 In this same period, technological improvements in transcatheter heart valve (THV) systems have led to a significant increase in efficacy and safety of TAVR. Newer-generation devices with external sealing skirts have addressed the issue of paravalvular regurgitation (PVR), and delivery systems with a smaller insertion profile allow for a safe transfemoral approach.

Abstract licence: CC BY-NC-ND

7 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.